2100 HD FloNavi Fluorescence Endoscopic Imaging System Acts as the Surgeon’s Third Eye

By HospiMedica International staff writers
Posted on 23 Feb 2022

OptoMedic Technologies, Inc.’s (Guangdong, China) 2100 HD FloNavi Fluorescence Endoscopic Imaging System can not only bring high-definition images to doctors, but also provide them with clearer fluorescent high-definition images with (ICG) Indocyanine Green Dye, acting as the third eye for surgeons.

Presently, fluorescence laparoscopy is becoming increasingly popular across the world. Considering that white light imaging has already become a household name, advanced fluorescence technology makes more sense amidst such a scenario. ICG has no side effects, enjoys wide application, has low cost and has been clinically approved since many years. ICG enters the human lymph and blood circulation through the tumor surrounding the tissue or via intravenous injection. ICG binds the plasma lipoproteins. After being exposed to NIR with a wavelength of 805 nm, the proteins emit a fluorescence signal with a wavelength of 835 nm. FloNavi captures the signal and fuses the signal onto white light imaging in real-time in order to achieve fluorescence mapping and navigation. Some of its applications are listed below:


Image: 2100 HD FloNavi Fluorescence Endoscopic Imaging System (Photo courtesy of OptoMedic Technologies, Inc.)

THORACIC SURGERY

HEPATOBILIARY SURGERY

STOMACH ENTEROCHIRURGIA

GYNAECOLOGY

URINARY SURGERY

Related Links:
OptoMedic Technologies, Inc. 


Latest Surgical Techniques News